Beyond access to drugs is access to knowledge
CAMR has failed to live up to its promise and is essentially a nightmare of red tape, political pandering, and missed opportunities, putting lives and Canada's international reputation on the line.
In May 2004, Canada became the first country in the world to announce it would amend its patent laws to allow Canadian generic drug producers to manufacture drugs for export to poor countries facing desperate health needs. Known then as the Jean Chrétien Pledge to Africa Act, the law passe...
SPONSORED CONTENT
Get Today’s Headlines Newsletter
Your quick scan of the news you need each weekday to be the smartest person in the room.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
